SEC Form 4 · accession 0001127602-19-007332
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gayle E Wilson
Director
Period of report
Feb 19, 2019
Accepted (ET)
Feb 20, 2019 · 8:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 19, 2019 | M | 19,068 | $0.00 | A | 143,567 | D | |
| Common StockF1 | Feb 19, 2019 | S | 19,068 | $67.0796 | D | 124,499 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F2 | $22.015 | Feb 19, 2019 | M | 19,068 | D | — | May 6, 2019 | Common Stock | 19,068 | 0 | D |
Explanation of responses
- F1Sale prices reported for the transactions reported here range from $67.07 to $67.10. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F2The options vested quarterly over the first year of service and were fully vested on May 6, 2010.